☆ 4.4 Letter

B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?

LANCET RHEUMATOLOGY (2020)

Get Full Text
Add to Collection

Journal

LANCET RHEUMATOLOGY
Volume 2, Issue 10, Pages E589-E590

Publisher

ELSEVIER
DOI: 10.1016/S2665-9913(20)30270-8

Keywords

-

Categories

Rheumatology

Funding

  1. MRC [MR/T024968/1] Funding Source: UKRI
  2. National Institute for Health Research [NIHR-INF-0958] Funding Source: researchfish

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.